Watson Pharmaceuticals (NYSE:WPI) received approval from the U.S. Food and Drug Administration for its generic version of a drug to treat C. difficile. Watson submitted an abbreviated new drug application for vancomycin hydrochloride capsules, USP, in 125 mg and 250 mg doses, used to treat diarrhea caused by C. difficile and for the treatment of […]
ViroPharma (NASDAQ:VPHM) has entered into an exclusive option to acquire Meritage Pharma, a San Diego, California-based company developing an orphan drug, in a deal valued at more than $69 million. Meritage is focused on using oral budesonide suspension as a treatment for eosinophilic esophagitis, a chronic inflammatory disorder of the esophagus. Eosinophilic esophagitis is a […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
ViroPharma (NASDAQ: VPHM) in Exton, Pennsylvania added to its orphan drug portfolio with its agreement to acquire DuoCort Pharma AB, a Sweden-based drug developer of Plenadren for adrenal insufficiency, in a $33.6 million deal. If the company meets certain milestones, associated with manufacturing, sales thresholds and territory expansion, it could get an additional $131 million. […]